A patient after an episode of acute coronary syndrome. Lipid control after acute coronary syndrome

Abstract

The review presents the recent data of clinical guidelines on the approved algorithms of lipid-lowering therapy prescription in patients with acute coronary syndrome. We indicated the targeted levels of lipid profile, which allow judging the treatment efficacy, as well as the difficulties faced by practitioners while prescribing high-intensity statins. The possibilities of combined therapy are identified for the management of patients of this category (additional prescription of ezetimibe and PCSK9 inhibitors). The review presents the positions of the approved consensus of the European Society of Cardiology specifying the approaches to lipid-lowering therapy in acute coronary syndrome. The available materials from foreign library databases (Library’s MEDLINE / PubMed database) were used to prepare the review.